GlobeNewsWire
24 Apr 2026, 19:40 UTC · 24w ago
Verdict
Headline takes no side. We score ANAB +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 90% of ticker scores this week
Which stocks this story touches
More positive than 90% of ticker scores this week
The court dismissed a breach of contract claim against the company and rejected a request for royalty reduction.
More negative than 75% of ticker scores this week
The company's subsidiary had its legal claims dismissed and faces ongoing litigation regarding breaches of a collaboration agreement.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 75% of relationship scores this week
[mutual] Anaptys has a Collaboration and Exclusive License Agreement with GSK's subsidiary Tesaro for the development and commercialization of Jemperli.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1h ago
−9.0%
Price is moving against the score
$46.67 vs $51.27 close before publication (Apr 23) · not market-adjusted
ANAB chart →
